Novel selective small molecule agonists for peroxisome proliferator-activated receptor δ (PPARδ)—synthesis and biological activity
Marcos L. Sznaidman, Curt D. Haffner, Patrick Maloney et al. · Bioorganic & Medicinal Chemistry Letters · 2003
Cited by 312 works. doi:10.1016/s0960-894x(03)00207-5
Authors
- Marcos L. Sznaidman
- Curt D. Haffner
- Patrick Maloney
- Adam M. Fivush
- Esther Y. H. Chao
- Donna M. Goreham
- Michael L. Sierra
- Christelle Le Grumelec
- H. Eric Xu
- Valerie G. Montana
- Millard H. Lambert
- Timothy Mark Willson
- William R. Oliver
- Daniel D. Sternbach
References
- An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ)
- Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
- Differential expression and activation of a family of murine peroxisome proliferator-activated receptors.
- The PPARs: From Orphan Receptors to Drug Discovery
- Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids
- A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport
- Molecular Recognition of Fatty Acids by Peroxisome Proliferator–Activated Receptors
- Sulfated Glycans Stimulate Endocytosis of the Cellular Isoform of the Prion Protein, PrPC, in Cultured Cells
- Orphan Nuclear Receptors: Shifting Endocrinology into Reverse
- Identification of a Chemical Tool for the Orphan Nuclear Receptor FXR